Search

48 search results for chris jones

Search results

New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

. Professor Chris Jones, Professor of Paediatric Brain Tumour Biology at The Institute of Cancer, Highly invasive human paediatric brain tumour derived cells. Image courtesy of Professor Chris Jones. A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease. The prototype treatment could, supported in the Jones lab with ACVR1 heading towards a biologically relevant treatment. Our hope very

Child brain tumour gene found

mutation – the first time this has ever been found in children,” says study leader Dr Chris Jones, drugs could be used in combination to treat some childhood gliomas,” Dr Jones says. “A future step

Protein ‘block’ kills childhood cancer cells

– the more active the protein, the more effective the treatment. Lead researcher Dr Chris Jones, from, as they do in patients and responded well to the drug. Dr Jones added: “This research shows the importance

Dr Rachael Natrajan

under the supervision of Dr Chris Jones at The Institute of Cancer Research in Sutton, where she

Researchers and groups

Professor Nick James Professor Chris Jones Professor Martin Kaiser Dr Astero Klampatsa Dr Gabriela Kramer-Marek Professor Kamil Kranc Dr Joanna Loizou Professor Chris, Group leader: Professor Chris Jones,  Dr Claudio Alfieri Dr Esther Arwert Professor Chris Bakal Professor Jeff Bamber, Dr Chiara Gorrini Jo Haviland Dr Beatrice Howard Dr Michael Jones Dr Zsofia Kote

New study discovers inhibitors of protein linked to the devastating childhood brain cancer DIPG

with the disease die within a year. ICR scientists led by Professor Chris Jones carried out pioneering

ICR childhood brain cancer research to benefit from funding boost announced by the Department of Health and Social Care and Cancer Research UK 

cancers. Read more Collaboration vital in childhood brain cancer research Professor Chris Jones, and Finish Working Group, led by the Government’s Chief Scientific Adviser Professor Chris Witty. Other

ICR one of founding institutions of new childhood cancer non-profit company

Development Unit at the Royal Marsden led by Dr Lynley Marshall. Professor Chris Jones’ achievements, in childhood cancer. Professors Jones and Chesler have led the development of excellent new, CONNECT consortium – co-led by Professor Jones – has opened another trial of lorlatinib, in infant

ICR Scientists at Forefront of High-Tech Gene Sequencing Initiative

workings of skin cancer.”A third project, led by ICR Team Leader Dr Chris Jones, will study a rare, always fatal.Dr Jones and colleagues will carry out whole genome sequencing on biopsy samples to create, Jones said. “Our study will be the most comprehensive ever carried out for Diffuse Intrinsic Pontine

Potential new drug to target rare childhood brain tumour

to be explored. Professor Chris Jones, Professor of Childhood Brain Tumour Biology at The Institute, visited Professor Chris Jones’ laboratory with her dad Sam has also since died. Sam Bainbridge